Skip to Main Content
February 2016  Volume 9Issue 2
Journal of Health and Life Sciences Law

Articles

King v. Burwell and the Retreat from Chevron

  • Ronald S. Connelly, Powers Pyles Sutter & Verville

To Promote or Not to Promote? The Enforceability of FDA’s Off-Label Marketing Restrictions Following Amarin

  • Matthew T. Newcomer, Post & Schell, P.C.
  • Yune T. Do, Post & Schell, P.C.

Searching for Certainty: OFCCP Jurisdiction Over Health Care Providers

  • Dara L. DeHaven, Ogletree Deakins Nash Smoak & Stewart PC
  • Leigh M. Nason, Ogletree Deakins Nash Smoak & Stewart PC

Behavioral Health and Population Health Management: Is It Time for Real Progress?

  • Arthur J. Fried, Epstein Becker Green
  • Paul A. Gomez, Polsinelli LLP
  • Purvi Badiani Maniar, Norton Rose Fulbright

Real Estate Industry Appraisal Practices versus Federal Health Care Regulations

  • Mary Beth F. Johnston, K&L Gates LLP
  • Amy O. Garrigues, K&L Gates LLP
  • Jon S. Zucker, K&L Gates LLP
Current Issue
February 2016